Filter by: patients

Fingolimod Treatment Report

Category: Prescription Drugs

Most Popular Types: Gilenya

false

See also: FTY720 (Fingolimod) Clinical Trial

Sort by: Helpfulness | Most Recent

3 patient evaluations for Fingolimod taken for the purpose of 'MS (Multiple Sclerosis)' with a perceived effectiveness rating of MajorMajorMajorMajorMajor

  • Tigertroll
    Sex: F
    Data Quality: 2 stars
    MS: 8 yrs
    Type: Relapsing-Remitting
    Sensation: Moderate
    Overall: Mild
    Cognition: none
    Vision: none
    Speech: none
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
  • 24432-thumb
  • See Tigertroll's full Fingolimod history
Purpose: MS (Multiple Sclerosis) (Started Oct 15, 2011)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Jul 10, 2012 0.5 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Date
Jul 10, 2012
Advice & Tips
I've had just one flare-up that lasted more than a week (felt like spiders crawling on me) in over a year on Gilenya. This is a HUGE improvement for me! Historically, I have had a new episode every 8-12 weeks, and was on a steroid regimen to calm it down at least twice a year.
  • Icon_thumb_on 2 helpful marks
  • Rick N
    Sex: M
    Data Quality: 3 stars
    MS: 24 yrs
    Mentor
    Type: Primary Progressive
    Sensation: Moderate
    Overall: Mild
    Cognition: moderate
    Vision: moderate
    Speech: mild
    Swallowing: none
    Upper limb: mild
    Walking: severe
  • 29865-thumb
  • See Rick N's full Fingolimod history
Purposes: MS (Multiple Sclerosis) and to slow down progression (Started Nov 11, 2011)
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness to slow down progression Perceived effectiveness Side Effects Adherence Burden
Apr 07, 2012 0.5 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Feb 06, 2012 0.5 mg Daily ?Can't tell NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Jan 17, 2012 0.5 mg Daily ?Can't tell NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Date
Apr 07, 2012
Advice & Tips
I hare found that Gilenya is convenient to adhere to and I have not side effects whatsoever. Ii have heard stories about sudden death from this treatment. Who knows why the deaths occured but 1000's of people are in this treatment. I tend to believe it is safe. One condition has been higher than normal colds and flu, Possibly dur to redused white cell / immunity
Cost
$25-49 monthly
Date
Feb 06, 2012
Advice & Tips
I like this treatment as opposed to daily shots.
Cost
$25-49 monthly
  • Icon_thumb_on 1 helpful mark
  • TickledPink
    Sex: F
    Data Quality: 2 stars
    MS: 14 yrs
    Type: Relapsing-Remitting
    Sensation: Mild
    Overall: None
    Cognition: mild
    Vision: none
    Speech: none
    Swallowing: none
    Upper limb: none
    Walking: moderate
  • 1468-thumb
  • See TickledPink's full Fingolimod history
Purpose: MS (Multiple Sclerosis) (Started Sep 21, 2010)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Oct 20, 2010 0.5 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major MildMildMildMildMild AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
Side effects:
Upper respiratory infection, UTI symptoms
Date
Oct 20, 2010
Advice & Tips
I had great improvement in all my MS symptoms, there were very few side effects. I was in the clinical trial for 3 years and continue for 1 more year in the extension phase. This drug has given me back my life. Minimal side effects, no hassle to take, have not yet had a relapse in over 3 years and was relapsing every 3 months prior to joining the trial.
Cost
< $25 monthly
  • Icon_thumb_on 32 helpful marks

33 additional evaluations for Fingolimod are not currently shared publicly.